PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Emerging and Re-Emerging Viruses, Department of Medical Microbiology & Infectious Diseases, University of Manitoba, Winnipeg R3T 2N2, Canada.\', \'Regenerative Medicine Program, Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg R3T 2N2, Canada.\', \'Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac, University of Saskatchewan, Saskatoon S7N 5E3, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1021/acsinfecdis.0c00579
?:hasPublicationType
?:journal
  • ACS infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 33319978
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.618
?:rankingScore_hIndex
  • 13
?:title
  • Integrating Proteomics for Facilitating Drug Identification and Repurposing During an Emerging Virus Pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all